Preparation and Evaluation of Nano-vesicles of Brimonidine Tartrate as an Ocular Drug Delivery System
2010

Nano-vesicles of Brimonidine Tartrate for Eye Treatment

Sample size: 18 publication 10 minutes Evidence: moderate

Author Information

Author(s): Prabhu P, Nitish Kumar R, Koland M, Harish NM, Vijayanarayan K, Dhondge G, Charyulu RN

Primary Institution: N.G.S.M. Institute of Pharmaceutical Sciences, Paneer, Deralakatte, Mangalore, India

Hypothesis

Can nano-vesicles of brimonidine tartrate improve drug delivery and reduce dosing frequency for ocular treatment?

Conclusion

The study found that nano-vesicles of brimonidine tartrate provide a sustained intraocular pressure-lowering effect compared to the pure drug solution.

Supporting Evidence

  • The vesicular formulations showed a sustained release of the drug over time.
  • IOP-lowering activity was significantly better with vesicular formulations compared to pure drug solutions.
  • Stability studies indicated that the formulations remained stable at 2-8°C.

Takeaway

This study shows that special tiny bubbles can help deliver eye medicine better and keep it working longer.

Methodology

Nano-vesicles were prepared using the film hydration method and evaluated for drug release and intraocular pressure-lowering activity in rabbits.

Potential Biases

Potential bias in animal model selection and treatment administration.

Limitations

The study was conducted on a small sample size and only in rabbits, which may limit generalizability to humans.

Participant Demographics

Normotensive male albino rabbits weighing 1.2-2.5 kg.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.4103/0975-1483.71623

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication